| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/31/2023 | 5.3% | Stifel | $97 → $92 | Maintains | Hold |
| 09/20/2023 | 40.78% | BMO Capital | $115 → $123 | Maintains | Outperform |
| 09/20/2023 | 53.37% | Baird | $125 → $134 | Maintains | Outperform |
| 08/28/2023 | 37.35% | Wolfe Research | → $120 | Initiates Coverage On | → Outperform |
| 08/04/2023 | 43.07% | Baird | $106 → $125 | Maintains | Outperform |
| 08/04/2023 | 38.49% | Goldman Sachs | $108 → $121 | Maintains | Buy |
| 06/22/2023 | 46.5% | Citigroup | $110 → $128 | Maintains | Buy |
| 05/03/2023 | 25.9% | Truist Securities | $100 → $110 | Maintains | Buy |
| 05/03/2023 | -5% | Stifel | $77 → $83 | Maintains | Hold |
| 02/22/2023 | 14.46% | Baird | $96 → $100 | Maintains | Outperform |
| 02/22/2023 | 9.88% | BMO Capital | $88 → $96 | Maintains | Outperform |
| 12/06/2022 | 0.72% | BMO Capital | $76 → $88 | Maintains | Outperform |
| 11/03/2022 | -13.01% | BMO Capital | $82 → $76 | Maintains | Outperform |
| 11/03/2022 | -3.86% | Citigroup | $85 → $84 | Maintains | Buy |
| 10/21/2022 | 15.6% | Goldman Sachs | → $101 | Initiates Coverage On | → Buy |
| 09/01/2022 | -1.57% | Citigroup | → $86 | Initiates Coverage On | → Buy |
| 08/10/2022 | -6.15% | BMO Capital | $75 → $82 | Maintains | Outperform |
| 06/28/2022 | 14.46% | Baird | $120 → $100 | Maintains | Outperform |
| 05/04/2022 | -8.44% | Stifel | $120 → $80 | Downgrades | Buy → Hold |
| 02/23/2022 | 37.35% | Stifel | $150 → $120 | Maintains | Buy |
| 02/01/2022 | 54.52% | BMO Capital | → $135 | Initiates Coverage On | → Outperform |
| 12/22/2021 | 71.68% | Stifel | $175 → $150 | Maintains | Buy |
| 02/19/2021 | 15.6% | Goldman Sachs | $60 → $101 | Maintains | Neutral |
| 02/18/2021 | 25.9% | Morgan Stanley | $82 → $110 | Maintains | Equal-Weight |
| 01/04/2021 | — | William Blair | Initiates Coverage On | → Outperform | |
| 12/17/2020 | -6.15% | Morgan Stanley | $52 → $82 | Upgrades | Underweight → Equal-Weight |
| 11/10/2020 | 0.72% | Berenberg | → $88 | Initiates Coverage On | → Buy |
| 11/05/2020 | -40.48% | Morgan Stanley | $48 → $52 | Maintains | Underweight |
| 08/05/2020 | -45.06% | Morgan Stanley | $30 → $48 | Maintains | Underweight |
| 05/01/2020 | -34.76% | SunTrust Robinson Humphrey | $65 → $57 | Maintains | Buy |
| 03/25/2020 | -65.66% | Morgan Stanley | $40 → $30 | Maintains | Underweight |
| 11/11/2019 | -47.35% | Goldman Sachs | → $46 | Initiates Coverage On | → Neutral |
| 10/16/2019 | -51.93% | Morgan Stanley | $46 → $42 | Maintains | Underweight |
What is the target price for Workiva (WK)?
The latest price target for Workiva (NYSE: WK) was reported by Stifel on October 31, 2023. The analyst firm set a price target for $92.00 expecting WK to rise to within 12 months (a possible 5.30% upside). 14 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Workiva (WK)?
The latest analyst rating for Workiva (NYSE: WK) was provided by Stifel, and Workiva maintained their hold rating.
When is the next analyst rating going to be posted or updated for Workiva (WK)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Workiva, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Workiva was filed on October 31, 2023 so you should expect the next rating to be made available sometime around October 31, 2024.
Is the Analyst Rating Workiva (WK) correct?
While ratings are subjective and will change, the latest Workiva (WK) rating was a maintained with a price target of $97.00 to $92.00. The current price Workiva (WK) is trading at is $87.37, which is out of the analyst's predicted range.